A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease, the authors reply

Research output: Contribution to journal › Letter › Scientific

1 Citation (Scopus)

Original language	English
Pages (from-to)	e57
Journal	The New England Journal of Medicine
Volume	385
Issue number	16
DOIs	https://doi.org/10.1056/NEJMc2112688
Publication status	Published - 14 Oct 2021
Publication type	B1 Journal article

Access to Document

@article{0935336e6d2d4baca01c2be786f327d0,

title = "A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease, the authors reply",

author = "Detlef Schuppan and Markku M{\"a}ki and Lundin, \{Knut E A\}",

year = "2021",

month = oct,

day = "14",

doi = "10.1056/NEJMc2112688",

language = "English",

volume = "385",

pages = "e57",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "16",

}

TY - JOUR

T1 - A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease, the authors reply

AU - Schuppan, Detlef

AU - Mäki, Markku

AU - Lundin, Knut E A

PY - 2021/10/14

Y1 - 2021/10/14

U2 - 10.1056/NEJMc2112688

DO - 10.1056/NEJMc2112688

M3 - Letter

C2 - 34644485

SN - 0028-4793

VL - 385

SP - e57

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 16

ER -